|
Biotecnologia Aplicada
Elfos Scientiae
ISSN: 0684-4551
Vol. 13, Num. 1, 1996
|
Biotecnologia Aplicada 1996 Volume 3 No. 1
Gene transfer for growth manipulation in Tilapia (Oreochromis
spp)
Jose de la Fuente,^1 Oscar Hernandez^,2 Rebeca Martinez^,1
Isabel Guillen,^1 Mario P. Estrada,^1 Edenaida Cabrera,^1
Diana Garcia del Barco,^1 Rafael Pimentel,^1 Reinold
Morales,^1 Fidel Herrera,^1 Antonio Morales,^1 Juan C. Pina,^1
Alina Rodriguez,^1 Vladimir Sanchez,^2 Zoila Abad,^2
Barbaro Ivarez^2 and Ricardo Lleonart^1
^ 1 Mammalian Cell Genetics Division. Center for Genetic
Engineering and Biotechnology. P.O.Box
6162. Habana 6, Cuba. ^2 Center for Genetic Engineering and
Biotechnology. P.O.Box 387. Camaguey 1, Cuba.
Code Number:BA96006
Size of Files:
Text: 4.8K
No associated graphics files
Tilapia are economically important species accounting for over
67 % of the fresh water fish production in Cuba. The
possibility of accelerating growth in tilapia was assayed by
exogenous administration of recombinant tiGH. The growth of
juvenile tilapia (Oreochromis spp.) was accelerated
(1,4 fold in length and 1,7 fold in body weight after 21 days)
when a Pichia pastoris-derived tiGH was administrated
by three intraperitoneal injections at intervals of 7 days.
The control group received BSA injections.
For gene transfer experiments, chimeric constructs were
prepared containing the tilapia growth hormone cDNA (tiGH) or
chromosomal gene (chr-tiGH), 5' regulatory sequences derived
from the human cytomegalovirus (CMV) or Rous sarcoma virus
(RSV), polyadenylation sites from the SV40 and the first
intron from the trout growth hormone gene (INT) (1-3).
Employing these constructs, tiGH transient expression was
obtained in mammalian and/or fish cells (1-3). Transient
expression experiments with these regulatory sequences
supported the hypothesis that different regulatory
requirements exist in cells and embryos and suggested that
chimeric constructs designed for transgenic experiments should
be assayed in transient expression experiments in fish embryos
(4). To evaluate the activity of different regulatory
elements in transgenic fish, five lines of transgenic tilapia
were generated (I: CMV >tiGH>CAT>SV40, II: CMV>+INT>tiGH>SV40,
III: CMV> -INT>tiGH>SV40, IV: RSV+INT>tiGH>SV40, and V:
RSV>chr-tiGH) by direct microinjection of one cell embryos
(5). With construct I, a transgenic animal containing 1 copy
of the transgene per cell was selected to establish a
transgenic line (F0-3 in (1) and afterwards designated as
albino) (5). The transgene was stably transmitted to
F1, F2 and F3 generations in a Mendelian fashion. Ectopic, low
level expression of tiGH was detected in gonad and muscle
cells of F1 transgenic tilapia by in situ hybridization
and immunohystochemical analysis of tissue sections. Nine
month old transgenic F1 progeny were 82% larger than
non-transgenic at p=0,001. These results showed that low level
ectopic expression of tiGH resulted in a growth acceleration
in this transgenic tilapia line. With the II-V constructs,
transgenic tilapia were generated carrying 8- >50 copies of
the transgene/genome. Transgenes were transmitted to F1
progeny in a Mendelian fashion.
Transgenic F1 tilapia with transgenes II-IV, showed only a
moderate increase in weight [II: 3,4% (p=0,0057), III: 3,3% (p
= 0,8) and IV: 5,0% (p=0,1)] when compared to non-transgenic
siblings. We are now characterizing the ectopic tiGH
expression levels in these transgenic tilapia to establish a
correlation with their growing phenotype. Although hormones
generally work at low concentrations, we need to compare the
growing phenotype of transgenic lines obtained with
different tiGH-containing chimeric constructs. Since we do not
know the optimum constitutive GH levels required for better
growth increase in tilapia, results have to be obtained
empirically comparing different constructs and transgenic
lines in heterozygous and homozygous animals, characterizing
the tissues and levels of ectopic tiGH expression.
Acknowledgements
Supported by the International Centre for Genetic Engineering
and Biotechnology Collaborative Research
Programme (project CRP/CUB93-05).
1. Martinez et al. Miami Short Reports 1992;2:53
2. Hernandez et al. Biotecnologia Aplicada
1993a;10:158-161
3. Hernandez et al. Molecular Marine Biology and
Biotechnology 1993b;2(3):181-188
4. Garcia del Barco et al. J. of Marine Biotechnology
1994;1:203-205
5. De la Fuente et al. J. of Marine Biotechnology
1995;(in press)
Copyright 1996 Elfos Scientiae
|